These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 2537989)

  • 1. The disposition of ethiofos (WR-2721) in the isolated perfused rat liver.
    Coleman MD; Fleckenstein L; Geary RS; Brewer TG; Timony GA; Mangold DJ
    Radiat Res; 1989 Feb; 117(2):334-41. PubMed ID: 2537989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disposition of the radioprotector ethiofos in the rhesus monkey. Influence of route of administration.
    Mangold DJ; Miller MA; Huelle BK; Sanchez-Barona DO; Swynnerton NF; Fleckenstein L; Ludden TM
    Drug Metab Dispos; 1989; 17(3):304-10. PubMed ID: 2568913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intraduodenal administration of ethiofos (WR-2721): dose proportionality study in the rhesus monkey.
    Geary RS; Swynnerton NF; Miller MA; Mangold DJ; Ludden T
    Res Commun Chem Pathol Pharmacol; 1989 Aug; 65(2):147-59. PubMed ID: 2555852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disposition of amphotericin B in the isolated perfused rat liver.
    Hong Y; Ramzan I; McLachlan AJ
    J Pharm Pharmacol; 2004 Jan; 56(1):35-41. PubMed ID: 14979999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The disposition of an antileishmanial 8-aminoquinoline drug in the isolated perfused rat liver: thermospray liquid chromatography-mass spectrometry identification of metabolites.
    Shipley LA; Coleman MD; Brewer TG; Ashmore RW; Theoharides AD
    Xenobiotica; 1990 Jan; 20(1):31-44. PubMed ID: 2327106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The disposition of primaquine in the isolated perfused rat liver. Effect of dose size.
    Ward SA; Mihaly GW; Nicholl DD; Edwards G; Breckenridge AM
    Drug Metab Dispos; 1985; 13(4):425-9. PubMed ID: 2863105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered hepatic disposition of doxorubicin in the perfused rat liver at hyperthermic temperatures.
    Skibba JL; Jones FE; Condon RE
    Cancer Treat Rep; 1982 Jun; 66(6):1357-63. PubMed ID: 7083240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of WR-1065 absorption in the rat small intestine.
    Geary RS; Swynnerton NF; Timmons SF; Mangold DJ
    Biopharm Drug Dispos; 1991 May; 12(4):275-84. PubMed ID: 1908337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A method for the combined measurement of ethiofos and WR-1065 in plasma: application to pharmacokinetic experiments with ethiofos and its metabolites.
    Swynnerton NF; Huelle BK; Mangold DJ; Ludden TM
    Int J Radiat Oncol Biol Phys; 1986 Aug; 12(8):1495-9. PubMed ID: 3019967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disposition of enalapril and its diacid metabolite, enalaprilat, in a perfused rat liver preparation. Presence of a diffusional barrier for enalaprilat into hepatocytes.
    Pang KS; Cherry WF; Terrell JA; Ulm EH
    Drug Metab Dispos; 1984; 12(3):309-13. PubMed ID: 6145558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjunctive use of ethiofos (WR-2721) with free radical-generating chemotherapeutic agents in mice: new caveats for therapy.
    Tabachnik Schor NF
    Cancer Res; 1987 Oct; 47(20):5411-4. PubMed ID: 2820568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and metabolism of the new thromboxane A2 receptor antagonist ramatroban in animals. 1st communication: absorption, concentrations in plasma, metabolism, and excretion after single administration to rats and dogs.
    Boberg M; Ahr HJ; Beckermann B; Bühner K; Siefert HM; Steinke W; Wünsche C; Hirayama M
    Arzneimittelforschung; 1997 Aug; 47(8):928-38. PubMed ID: 9296279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Corticosteroid metabolism in isolated perfused rat liver and kidney. Experimental studies with emphasis on aldosterone.
    Egfjord M
    Acta Physiol Scand Suppl; 1995; 627():1-42. PubMed ID: 8848946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. WR-2721 entry into the brain across a modified blood-brain barrier.
    Lamperti A; Conger AD; Jenkins O; Cohen G; Rizzo A; Davis ME; Sodicoff M
    Radiat Res; 1988 Aug; 115(2):303-13. PubMed ID: 2841714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disposition and metabolism of the new hypocholesterolemic compound S-8921 in rats and dogs.
    Yamaguchi T; Nakajima Y; Mizobuchi M; Inazawa K; Kanazu T; Kadono K; Ohkawa T; Iwatani K
    Arzneimittelforschung; 1998 Oct; 48(10):995-1006. PubMed ID: 9825117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Orally active inhibitors of human leukocyte elastase. I. Disposition of L-683,845 in rats and rhesus monkeys.
    Vincent SH; Painter SK; Krieter PA; Colletti AE; Lyszack E; Rosegay A; Dean D; Luffer-Atlas D; Miller RR; Cioffe C; Chiu SH
    Drug Metab Dispos; 1996 Dec; 24(12):1369-77. PubMed ID: 8971144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of ethiofos absorption in the rat small intestine.
    Geary RS; Swynnerton NF; Timmons SF; Mangold DJ
    Biopharm Drug Dispos; 1991 May; 12(4):261-74. PubMed ID: 1651790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purging of small cell lung cancer cells from human bone marrow using ethiofos (WR-2721) and light-activated merocyanine 540 phototreatment.
    Meagher RC; Rothman SA; Paul P; Koberna P; Willmer C; Baucco PA
    Cancer Res; 1989 Jul; 49(13):3637-41. PubMed ID: 2543500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The disposition of suramin in the isolated perfused rat liver.
    Coleman MD; Adjepon-Yamoah KK
    Biochem Pharmacol; 1986 Oct; 35(19):3389-92. PubMed ID: 3768027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Behavioral toxicity and efficacy of WR-2721 as a radioprotectant.
    Bogo V; Jacobs AJ; Weiss JF
    Radiat Res; 1985 Nov; 104(2 Pt 1):182-90. PubMed ID: 3001816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.